Arrivent Biopharma Inc (AVBP)
23.29
-0.04%
Arrivent Biopharma Inc (AVBP) is currently trading at $23.29. This represents a loss of 0.04% from the previous session. With a market capitalization of $0.96B, AVBP is a key component of the Biotechnology sector. Investors looking to trade AVBP should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade AVBP commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Arrivent Biopharma Inc (AVBP) shows a bearish trend. Analysts are watching the 23.79 level closely.
Fundamentals
Mkt Cap0.96B
P/E Ratio0.0000
Volume280,354
Others Watching (By Market Cap)
JBIOJade Bioscience $14.50
+4.47% ANRO
Alto Neuroscien $18.99
-1.71% NMRA
Neumora Therape $3.46
+0.87% LXEO
Lexeo Therapeut $6.89
+2.99%
60-Day Technical Chart
Advanced Charting
Need more indicators for AVBP? Use the world's #1 platform.
Open AVBP on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $23
| Metric |
AVBP -0.04% |
BMNR +10.60% |
TTD +0.88% |
HL -1.40% |
|---|---|---|---|---|
| Price | $23.29 | $21.51 | $25.16 | $23.31 |
| Mkt Cap | $0.96B | $9.80B | $12.33B | $15.63B |
| - | View → | View → | View → |
Latest Headlines
Here's Why We're Watching ArriVent BioPharma's (NASDAQ:AVBP) Cash Burn Situation
simplywall.st • Nov 13, 2025
ArriVent BioPharma: A De-Risked Binary With Near-Term Catalysts (NASDAQ:AVBP)
Seeking Alpha • Dec 25, 2025
Trading Systems Reacting to (AVBP) Volatility
Stock Traders Daily • Feb 7, 2026
ArriVent BioPharma: Its Leading Asset, Furmonertinib, Supports A Cautious Buy
Seeking Alpha • Jan 4, 2026
ArriVent BioPharma (AVBP): Among the Best Short Squeeze Stocks to Buy According to Analysts
Yahoo Finance • Mar 19, 2025
● Gemini Agentic AI Analyst Insight for AVBP
Market Education
- Are Cruise Stocks Finally Back on Course After a Rocky Five Years? Sep 27, 2025
- 10 rules of money - Follow this and you are set for life Jul 16, 2023
- Penny Stock List Nov 19, 2023
External Research